Author pages are created from data sourced from our academic publisher partnerships and public sources.
Effect of an enhanced medical home on serious illness and cost of care among high-risk children with chronic illness: a randomized clinical trial.
IMPORTANCE Patient-centered medical homes have not been shown to reduce adverse outcomes or costs in adults or children with chronic illness. OBJECTIVE To assess whether an enhanced medical home… Expand
Correlation between annual volume of cystectomy, professional staffing, and outcomes
The association between high procedure volume and lower perioperative mortality is well established among cancer patients who undergo cystectomy. However, to the authors' knowledge, the association… Expand
Clinical model of lifetime cost of treating bladder cancer and associated complications.
OBJECTIVES To estimate the lifetime cost of bladder cancer and the contribution of complications to the total costs. METHODS We reviewed the medical records of a retrospective cohort of 208… Expand
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia.
- L. Elting, C. Lu, +10 authors K. Rolston
- Journal of clinical oncology : official journal…
- 1 February 2008
PURPOSE We retrospectively compared the outcomes and costs of outpatient and inpatient management of low-risk outpatients who presented to an emergency department with febrile neutropenia (FN). … Expand
Outcomes and cost of deep venous thrombosis among patients with cancer.
BACKGROUND Although deep venous thrombosis (DVT) often complicates the clinical course in patients with cancer, few studies of the outcomes of DVT in this population have been published. Furthermore,… Expand
Generalizability of cancer clinical trial results
The generalizability of clinical trial results is questionable, because fewer than 5% of cancer patients participate. The authors examined the comparability of clinical trial participants and… Expand
Epidemiology and outcomes of serious influenza‐related infections in the cancer population
- C. Cooksley, E. Avritscher, B. Bekele, K. Rolston, J. M. Geraci, L. Elting
- 1 August 2005
Although patients with cancer generally respond favorably to vaccination, they may not receive annual influenza vaccinations. The current population‐based study described the epidemiology and… Expand
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer
- J. Jones, E. Avritscher, C. Cooksley, M. Michelet, B. Bekele, L. Elting
- Supportive Care in Cancer
- 7 April 2006
Goals of work: Oral and gastrointestinal (GI) mucositis are frequent complications of chemotherapy and radiotherapy for cancer, contributing to not only the morbidity of treatment but its cost as… Expand
Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis.
OBJECTIVE To discuss the scope and epidemiology of cancer therapy-induced mucositis. DATA SOURCE Peer-reviewed articles and book chapters. CONCLUSION Mucositis is a frequent and costly… Expand
Mammography capacity impact on screening rates and breast cancer stage at diagnosis.
- L. Elting, C. Cooksley, +5 authors Richard Theriault
- American journal of preventive medicine
- 1 August 2009
BACKGROUND Mammography capacity in the U.S. reportedly is adequate, but has not been examined in nonmetropolitan areas. This study examined the relationships between in-county mammography facilities… Expand